Skip to content

Improving cardiovascular health in dialysis patients using a structured programme of exercise (CYCLE-HD)

A randomised, cluster controlled trial to investigate the effects of a programme of intradialytic exercise on cardiovascular outcomes in haemodialysis patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN11299707
Enrollment
130
Registered
2015-03-05
Start date
2015-03-16
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Renal disorders

Interventions

The study will compare six month of cycling exercise during dialysis (intervention group) against normal dialysis care (no intervention). The intervention group will use specially adapted and calibrat

Sponsors

University of Leicester (UK)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Be a prevalent haemodialysis patient (on haemodialysis for more than 3 months) 2. Age 18 years or older 3. Able and willing to give informed consent

Exclusion criteria

Exclusion criteria: 1. Unable to participate in current exercise program due to perceived physical or psychological barriers 2. Unable to undergo MRI scanning (metal implants / prostheses, claustrophobia etc.) 3. Unfit to undertake exercise according to the American College of Sports Medicine guidelines 4. Contraindications to exercise testing (35) that include: 4.1. Recent significant change in resting ECG that suggests significant ischaemia, recent myocardial infarction (2 weeks) or other acute cardiac event; 4.2. Unstable angina; 4.3. Uncontrolled cardiac dysrhythmias causing symptoms or haemodynamic compromise; 4.4. Symptomatic severe aortic stenosis 4.5. Uncontrolled symptomatic heart failure 4.6. Acute pulmonary embolus or pulmonary infarction 4.7. Acute myocarditis or pericarditis 4.8. Suspected or known dissecting aneurysm 4.9. Acute systemic infection, accompanied by fever, body aches or swollen lymph glands 5. Age <18 years 6. Unable or unwilling to give informed consent

Design outcomes

Primary

MeasureTime frame
Reduction in left ventricular mass; Timepoint(s): Measured at baseline and after 6-months of exercise intervention.

Secondary

MeasureTime frame
1. Measurements of cardiac structure and function measured using MRI and echocardiography (e.g. left ventricular ejection fraction, blood oxygen delivery) 2. Cardiac rhythm measured using 48 hour ambulatory monitoring 3. Non-invasive cardiac measurements (e.g.blood pressure) 4. Measurements of height, weight, waist circumference and body composition analysis 5. Physical functioning measures including walking and standing tests 6. Objective assessment of habitual physical activity using accelerometry 7. Quality of life and perceived function scores using a variety of validated questionnaires 8. Blood markers of myocardial dysfunction and risk 9. Blood markers of the malnutrition and inflammation

Countries

England, United Kingdom

Contacts

Public ContactJames Burton
dsm12@le.ac.uk+44 (0)116 2584042

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 23, 2026